
The U.S. Pharmaceuticals Industry in 2025: Innovation, Challenges, and Shifting Dynamics
The U.S. pharmaceuticals industry is entering 2025 with a mix of promising opportunities and significant challenges. From the continued growth of GLP-1 drugs to shifting supply chain strategies and evolving regulatory landscapes, companies are navigating a […]